Functional Trunk Training
OtherThe intervention includes neurodevelopment treatment, muscle strengthening and functional activities of trunk region
NCT Number: NCT02643160
The purpose of this study is to analyze if trunk training has effects on trunk, upper, lower extremity motor functions in children with spastic Cerebral Palsy. Second purpose is to analyze the relation between trunk control and prematurity, birth weight, upper and lower extremity motor functions in children with spastic Cerebral Palsy.
Looking for future studies?
Notify Me4 year–18 year
All sexes
Interventional
Not applicable
Cerebral Palsy (CP) is a condition caused by a lesion occurred in immature brain during prenatal, natal or postnatal period. Children with CP may have motor, cognitive, sensory, auditory, behavioral problems during their lifespan. Spastic type CP is most common type of CP and many children with spastic CP have both trunk and limb impairment. Physiotherapy is very important for improving motor function and protect from secondary impairments in this children and should start as early as possible. The aim of this study is to analyze if trunk training has effects on trunk, upper and lower extremity motor function in children with spastic CP. 38 children with spastic CP between 4-18 years age are included in this study. Both genders are included. The Participants randomized according to their gross motor function classification system levels and their age. Before intervention all groups assessed with assessment tools which assess muscle spasticity, balance, gross motor function, trunk control and walking characteristics. After randomization there wasn't any intervention for control group; they continued their regular physiotherapy in special education centers two times a week. Study group received trunk training two times a week in addition to their regular physiotherapy in special education centers during 8 weeks. After 8 weeks all groups assessed with the same assessment tools.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention includes neurodevelopment treatment, muscle strengthening and functional activities of trunk region
Time frame: At baseline and 8 weeks after baseline
Assessing change in trunk control
Time frame: At baseline and 8 weeks after baseline
Assessment of child's daily living activities and participation
Time frame: At baseline and 8 weeks after baseline
Assessment of muscle activation
Time frame: At baseline and 8 weeks after baseline
Assessing muscle spasticity
Time frame: At baseline and 8 weeks after baseline
Assessing gross motor function
Time frame: At baseline and 8 weeks after baseline
Assessing upper extremity skills
Time frame: At baseline and 8 weeks after baseline
Assessing loco motion.
Time frame: At baseline and 8 weeks after baseline
Assessing walking parameters
Time frame: At baseline and 8 weeks after baseline
Assessing functional loco motion
Time frame: At baseline and 8 weeks after baseline
Assessing walking speed
Time frame: At baseline and 8 weeks after baseline
Assessing balance
Time frame: At baseline and 8 weeks after baseline
Assessing impact on family to have a disabled child
Time frame: At baseline and 8 weeks after baseline
Assessing independence level
Abant Izzet Baysal University
Other
Analyzing the Effect of Functional Trunk Training on Upper and Lower Limb Motor Function in Children With Spastic Cerebral Palsy
Acronym: FTT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05269745
Brain Damage, Chronic, Brain Diseases
Graz, Styria, Austria
View Trial DetailsNCT06676540
Brain Damage, Chronic, Brain Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT03863197
Brain Damage, Chronic, Brain Diseases
Ghent, Belgium
View Trial DetailsNCT06554990
Brain Damage, Chronic, Brain Diseases
Cairo, Egypt
View Trial Details